In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d.
Publication
, Journal Article
Allan, T; Newby, LK; ACP Journal Club Editorial Team at McMaster University
Published in: Ann Intern Med
January 2026
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 2026
Volume
179
Issue
1
Start / End Page
JC9
Location
United States
Related Subject Headings
- RNA, Small Interfering
- Middle Aged
- Male
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- General & Internal Medicine
- Female
- Drug Therapy, Combination
- Cholesterol, LDL
Citation
APA
Chicago
ICMJE
MLA
NLM
Allan, T., Newby, L. K., & ACP Journal Club Editorial Team at McMaster University. (2026). In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d. Ann Intern Med, 179(1), JC9. https://doi.org/10.7326/ANNALS-25-05115-JC
Allan, Tess, L Kristin Newby, and ACP Journal Club Editorial Team at McMaster University. “In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d.” Ann Intern Med 179, no. 1 (January 2026): JC9. https://doi.org/10.7326/ANNALS-25-05115-JC.
Allan T, Newby LK, ACP Journal Club Editorial Team at McMaster University. In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d. Ann Intern Med. 2026 Jan;179(1):JC9.
Allan, Tess, et al. “In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d.” Ann Intern Med, vol. 179, no. 1, Jan. 2026, p. JC9. Pubmed, doi:10.7326/ANNALS-25-05115-JC.
Allan T, Newby LK, ACP Journal Club Editorial Team at McMaster University. In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d. Ann Intern Med. 2026 Jan;179(1):JC9.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 2026
Volume
179
Issue
1
Start / End Page
JC9
Location
United States
Related Subject Headings
- RNA, Small Interfering
- Middle Aged
- Male
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- General & Internal Medicine
- Female
- Drug Therapy, Combination
- Cholesterol, LDL